Healthy Returns: FDA launches program to streamline creation of new...
FDA's PreCheck program aims to boost U.S. drug manufacturing by reducing regulatory hurdles.
FDA's PreCheck program aims to boost U.S. drug manufacturing by reducing regulatory hurdles.
President Donald Trump signed an executive order Monday aimed at boosting domestic drug manufacturing in the U.S., as potential tariffs on imported pharmaceuticals draw closer. The order seeks to streamline...